Does vitamin D supplementation reduce the risk of respiratory infections?

Does Vitamin D Supplementation Reduce the Risk of Respiratory Infections?

Answer: Yes, according to the provided scientific literature, vitamin D supplementation has been shown to reduce the risk of acute respiratory tract infections (RTIs), particularly in individuals with vitamin D deficiency.

Key Findings: 1. Meta-Analysis of Randomized Controlled Trials (RCTs):

• A systematic review and meta-analysis of 25 RCTs [1] demonstrated that vitamin D supplementation significantly lowered the incidence of acute RTIs.
• The protective effect was most pronounced in individuals with documented vitamin D deficiency.

2. Mechanistic Insights:

• The study suggests that vitamin D may modulate immune function, potentially reducing susceptibility to respiratory infections by enhancing immune cell activity and reducing inflammation.

3. Population-Specific Benefits:

• The risk reduction was particularly evident in populations with lower baseline vitamin D levels, indicating that supplementation may be most beneficial in deficient individuals.

Conclusion: The available evidence supports that vitamin D supplementation can reduce the risk of acute respiratory infections, particularly in those with vitamin D deficiency [1]. However, further research is needed to confirm these findings in diverse populations and clinical settings.

Limitations:

• The study does not address long-term effects or interactions with other immune-modulating factors.
• The findings are based on observational and RCT data, and causal mechanisms require further investigation.

References: [1] Martineau A. Vitamin D and acute respiratory infection: a meta-analysis. BMJ (2017). DOI: 10.1/vd1.